SIA
FLACU

Schechter Investment Advisors’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Schechter Investment Advisors’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,400
Closed -$132K – 1032
2022
Q1 		$132K Hold
13,400
– – 0.01% 874
2021
Q4 		$133K Buy
+13,400
New +$134K 0.01% 830

Other funds holding FLACU

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Schechter Investment Advisors's FLACU Position: Q2 2022 in Review

Schechter Investment Advisors sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q2 2022, closing a stake of 13,400 shares — an estimated $132K sold.

Schechter Investment Advisors first reported a position in FLACU in Q4 2021 and held it in 2 quarters. The position peaked at $133K in Q4 2021. 17 funds tracked by Wall St. Rank hold FLACU as of Q2 2022.

  • Schechter Investment Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q2 2022 after selling out during the quarter.
  • Schechter Investment Advisors sold 13,400 Frazier Lifesciences Acquisition Corporation Unit shares in Q2 2022, an estimated $132K.
  • Schechter Investment Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2021 and held it in 2 quarters.
  • Schechter Investment Advisors's Frazier Lifesciences Acquisition Corporation Unit position peaked at $133K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q2 2022.

Based on Schechter Investment Advisors's 13F filing for Q2 2022, filed 3 Nov 2022.